Загрузка...
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer’s disease
Clinical trial outcomes for Alzheimer’s disease are typically analyzed by using the mixed model for repeated measures (MMRM) or similar models that compare an efficacy scale change from baseline between treatment arms with or without participants’ disease stage as a covariate. The MMRM focuses on a...
Сохранить в:
| Опубликовано в: : | Stat Med |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6105413/ https://ncbi.nlm.nih.gov/pubmed/29761523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.7811 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|